Active selexipag metabolite MRE-269 increases endothelin receptors in pulmonary artery smooth muscle cells

Back

ESC Premium Access

Active selexipag metabolite MRE-269 increases endothelin receptors in pulmonary artery smooth muscle cells

Session: Basic mechanisms of pulmonary disease

Topic: Pharmacotherapy

Speaker: Doctor H. Maruyama (Tsuchiura, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)

1 presentation

0 follower

6 more presentations in this session

Cardiovascular coupling and elastic properties of pulmonary artery in different phenotypes of patients with pulmonary hypertension

Speaker: Doctor I. Lyapina (Kemerovo, RU)

Access

Abstract

Slides

Inhibin Beta-A is a novel gene involved in the development of pulmonary arterial hypertension through inhibiting BMPRII-signaling in endothelial cells

Speaker: Doctor G. Ryanto (Kobe, JP)

Access

Abstract

Slides

Poor outcomes in pulmonary arterial hypertension as a member of RNF213-associated vascular diseases

Speaker: Doctor T. Hiraide (Tokyo, JP)

Access

Abstract

Slides

Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution

Speaker: Doctor T. Hofbauer (Vienna, AT)

Access

Abstract

NKX2-5 contributes to EndoMT and endothelial dysfunction in pulmonary arterial hypertension

Speaker: Mr J. Santos Cade (London, GB)

Access

Abstract

Slides

Access the full session

Basic mechanisms of pulmonary disease

Speakers: Doctor H. Maruyama, Doctor I. Lyapina, Doctor G. Ryanto, Doctor T. Hiraide, Doctor T. Hofbauer...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources